Author: Ko, Dae-Hyun; Kim, Hyun Soo; Hyun, Jungwon; Kim, Han-Sung; Kim, Jae-Seok; Park, Kyoung Un; Song, Wonkeun
Title: Comparison of the Luminex xTAG Respiratory Viral Panel Fast v2 Assay With Anyplex II RV16 Detection Kit and AdvanSure RV Real-Time RT-PCR Assay for the Detection of Respiratory Viruses Document date: 2017_6_20
ID: vic6rbnb_2
Snippet: Luminex technology has been widely adopted in clinical laboratories for various tests such as multiplex PCR, human leukocyte antigen tests, and protein assays [10, 11] . The Luminex xTAG respiratory viral panel (RVP) and RVP FAST v1 assays (Luminex Molecular Diagnostics, Toronto, Canada) proved to be clinically useful in previous studies [12] [13] [14] [15] , and a revised version (xTAG RVP Fast v2) (Luminex Molecular Diagnostics) was recently re.....
Document: Luminex technology has been widely adopted in clinical laboratories for various tests such as multiplex PCR, human leukocyte antigen tests, and protein assays [10, 11] . The Luminex xTAG respiratory viral panel (RVP) and RVP FAST v1 assays (Luminex Molecular Diagnostics, Toronto, Canada) proved to be clinically useful in previous studies [12] [13] [14] [15] , and a revised version (xTAG RVP Fast v2) (Luminex Molecular Diagnostics) was recently released in 2013. The Luminex xTAG RVP Fast v2 assay is a multiplex reverse transcriptase (RT)-PCR assay that is incorporated with the Luminex tagging system. Following the first release of the Luminex xTAG RVP assay, Luminex Molecular Diagnostics issued a revised version. The new assay have several advantages over the other assays: 1) detect more types of viruses (19 strains); 2) distinguish among influenza A subtypes (H1, H3, 2009 H1N1), coronavirus HKU1, and parainfluenza type 4; 3) handle the largest number of specimens in one run (94 specimens); 4) use a small specimen volume (10 μL of nucleic acids); and 5) produce semi-quantitative results as the fluorescence intensity.
Search related documents:
Co phrase search for related documents- antigen test and large number: 1, 2
- antigen test and Luminex xTAG: 1
- antigen test and multiplex reverse transcriptase: 1
- antigen test and new assay: 1, 2, 3
- antigen test and previous study: 1, 2, 3, 4, 5
- antigen test and protein assay: 1, 2
- assay advantage and clinical laboratory: 1
- assay advantage and new assay: 1, 2
- assay advantage and previous study: 1, 2
- clinical laboratory and fluorescence intensity: 1
- clinical laboratory and human leukocyte: 1
- clinical laboratory and influenza subtype: 1, 2, 3, 4, 5
- clinical laboratory and large number: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
- clinical laboratory and multiplex reverse transcriptase: 1, 2
- clinical laboratory and new assay: 1, 2, 3
- clinical laboratory and previous study: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
- clinical laboratory and protein assay: 1, 2, 3, 4, 5, 6, 7, 8
- FAST v1 assay and Luminex xTAG: 1, 2
- FAST v1 assay and Luminex xtag RVP assay: 1, 2
Co phrase search for related documents, hyperlinks ordered by date